Our expert health economists can help you assess and communicate your product’s value throughout its lifecycle to your key stakeholders--patients, health care providers, payers and regulators. We develop and implement tools and strategies to demonstrate the global economic impact of new and existing drugs in the context of health outcomes, so you can in turn make better development and commercialization decisions. There are several key measures that we use to determine the economic impact of an illness or your product:
Economic Outcomes
Direct costs - use of health care resources
Indirect costs - changes in productivity
Intangible costs - health-related quality of life (HRQoL) and patient satisfaction
Clinical Outcomes - Change in health status
Specifically, your health economic value assessment may include the study of the following key influencers to fully understand the economic implications of your drug:
Burden of Illness
Disease incidence and prevalence, cost estimates, symptoms and current therapies
Market Assessment
Stakeholder needs, patient stratification and effective messaging
Clinical Benefits
Efficacy, safety and risk-benefit profiles
Patient Outcomes
Quality of life, functional status, preferences, caregiver burden, satisfaction and adherence
Resource Utilization
Treatment and utilization patterns, associated costs and lost productivity
Economic Value
Cost-effectiveness, cost-utilization, cost-benefits, cost consequences and the associated budget and population impact
Methods
To gain credible evidence that supports the economic value of your product, we use the following methods:
Our health economics services help you select among potential drug candidates; make pricing decisions; achieve formulary acceptance; gain reimbursement; understand your market; differentiate your product from competing drugs, generics, and OTCs; and respond to health care budget constraints.
Deliverables
You will benefit from our quality-assured deliverables, including:
Custom models and accompanying reports
Health economic strategy documents
Economic regulatory submission documents and formulary dossiers
Interactive model software
Presentations at professional meetings
Peer-reviewed journal articles and abstracts
Training courses, seminars and workshops
Literature review reports
Related Services
For your benefit, we offer a variety of services that complement our health economics work:
